- Filed
- Feb 18, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 11, 2026 | 816M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 711M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 713M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 709M sh |
| Shares Diluted restated | Q2 2026 · Jan 31, 2025 | 709M sh |
| Operating Cash Flow | Q2 2026 · Jan 31, 2026 | $2.33B |
| Operating Cash Flow restated | Q2 2026 · Jan 31, 2025 | $2.07B |
| Short Term Investments | Q2 2026 · Jan 31, 2026 | $378M |
| Short Term Investments | Q2 2026 · Jul 31, 2025 | $635M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2026 | $4.16B |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $2.27B |
| Cash And Equivalents restated | Q2 2026 · Jan 31, 2025 | $2.23B |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | $9.39B |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $8.67B |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $7.82B |
| Stockholders Equity restated | Q2 2026 · Jan 31, 2025 | $6.38B |
| Stockholders Equity restated | Q2 2026 · Oct 31, 2024 | $5.91B |
| Stockholders Equity restated | Q2 2026 · Jul 31, 2024 | $5.17B |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $8.01B |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $7.99B |
| Total Liabilities | Q2 2026 · Jan 31, 2026 | $15.59B |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $15.75B |
| Current Assets | Q2 2026 · Jan 31, 2026 | $8.37B |
| Current Assets | Q2 2026 · Jul 31, 2025 | $7.52B |
| Total Assets | Q2 2026 · Jan 31, 2026 | $24.98B |
| Total Assets | Q2 2026 · Jul 31, 2025 | $23.58B |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $0.61 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $1.07 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $0.38 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $0.87 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $0.61 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $1.10 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $0.41 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $0.94 |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $178M |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $357M |
| Sga Expense restated | Q2 2026 · Jan 31, 2025 | $154M |
| Sga Expense restated | Q2 2026 · Jan 31, 2025 | $252M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $511M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $1.04B |
| Rd Expense restated | Q2 2026 · Jan 31, 2025 | $505M |
| Rd Expense restated | Q2 2026 · Jan 31, 2025 | $986M |
| Net Income | Q2 2026 · Jan 31, 2026 | $432M |
| Net Income | Q2 2026 · Jan 31, 2026 | $766M |
| Net Income restated | Q2 2026 · Jan 31, 2025 | $267M |
| Net Income | Q2 2026 · Jan 31, 2025 | $618M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $397M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $706M |
| Operating Income restated | Q2 2026 · Jan 31, 2025 | $241M |
| Operating Income restated | Q2 2026 · Jan 31, 2025 | $527M |
| Gross Profit | Q2 2026 · Jan 31, 2026 | $1.91B |
| Gross Profit | Q2 2026 · Jan 31, 2026 | $3.75B |
| Gross Profit restated | Q2 2026 · Jan 31, 2025 | $1.66B |
| Gross Profit restated | Q2 2026 · Jan 31, 2025 | $3.24B |
| Cost Of Revenue | Q2 2026 · Jan 31, 2026 | $685M |
| Cost Of Revenue | Q2 2026 · Jan 31, 2026 | $1.32B |
| Cost Of Revenue restated | Q2 2026 · Jan 31, 2025 | $599M |
| Cost Of Revenue restated | Q2 2026 · Jan 31, 2025 | $1.15B |
| Revenue | Q2 2026 · Jan 31, 2026 | $2.59B |
| Revenue | Q2 2026 · Jan 31, 2026 | $5.07B |
| Revenue restated | Q2 2026 · Jan 31, 2025 | $2.26B |
| Revenue restated | Q2 2026 · Jan 31, 2025 | $4.4B |